Skip to content

Schrodinger SDGR Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

Revvity logo
RevvityRVTY
PDF Solutions logo
PDF SolutionsPDFS
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-19.7%
Enterprise value$984.71M-18.3%
P/S4.5×-1.7×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's proceeds from exercises of stock options and other stock issuances?
Schrodinger (SDGR) reported proceeds from exercises of stock options and other stock issuances of $583K in Q1 2026.
How has Schrodinger's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Schrodinger's proceeds from exercises of stock options and other stock issuances increased by 37.8% year-over-year, from $423K to $583K.
What is the long-term trend for Schrodinger's proceeds from exercises of stock options and other stock issuances?
Over 2 years (2022 to 2025), Schrodinger's proceeds from exercises of stock options and other stock issuances has grown at a 19.0% compound annual growth rate (CAGR), from $2.11M to $2.99M.